AbCellera Biologics Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of ABCL for the last quarter is 9.95 M USD, and it's 8.44% higher compared to the previous quarter. The net income of Q1 24 is -40.61 M USD.